Study questions whether mistaken antibodies led cancer research down a 20-year dead end
Thursday, June 15, 2017 - 09:22
in Health & Medicine
For nearly two decades researchers have sought a way to target an estrogen receptor in the hope they could improve breast cancer survival, but a new article contends that the effort may never pan out. The reason? The target receptor does not actually appear to be where they believe it to be.